Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

NeoGenomics, Inc. (NEO)

9.69   0.58 (6.37%) 06-26 22:16
Open: 9.16 Pre. Close: 9.11
High: 9.76 Low: 8.93
Volume: 8,265,176 Market Cap: 1,209(M)
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.77 - 9.81 9.81 - 9.85
Low: 8.84 - 8.88 8.88 - 8.92
Close: 9.62 - 9.69 9.69 - 9.77

Technical analysis

as of: 2022-06-24 4:41:52 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 11.39     One year: 13.31
Support: Support1: 7.96    Support2: 6.84
Resistance: Resistance1: 9.76    Resistance2: 11.39
Pivot: 7.93
Moving Average: MA(5): 8.34     MA(20): 8.05
MA(100): 13.28     MA(250): 29.36
MACD: MACD(12,26): -0.2     Signal(9): -0.5
Stochastic oscillator: %K(14,3): 83.4     %D(3): 61.7
RSI: RSI(14): 61.4
52-week: High: 54.74  Low: 6.84
Average Vol(K): 3-Month: 2,403 (K)  10-Days: 2,611 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ NEO ] has closed above the upper band by 11.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 37.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 26 Jun 2022
The first neo-financial institution in KSA opts for ICS BANKS Digital Platform from ICSFS - ZAWYA

Sat, 25 Jun 2022
The 10 Best '80s Neo-Noir Movies, According To Reddit - Screen Rant

Sat, 25 Jun 2022
Martin Hinteregger retires at 29 after outrage over links to Austrian Neo-Nazi figure - Daily Mail

Fri, 24 Jun 2022
Samsung Neo G8 vs Samsung Neo G9 - TrustedReviews

Thu, 23 Jun 2022
AYA NEO AIR series debuts on Indiegogo from US$499 with AMD Barcelona APUs and OLED displays - Notebookcheck.net

Thu, 23 Jun 2022
How Russia Uses Neo-Nazi Groups to Spread Chaos - Voice of America - VOA News

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 123 (M)
Shares Float 120 (M)
% Held by Insiders 2.5 (%)
% Held by Institutions 91.6 (%)
Shares Short 5,510 (K)
Shares Short P.Month 5,220 (K)

Stock Financials

EPS 0.4
EPS Est Next Qtl 0.03
EPS Est This Year 0.12
EPS Est Next Year 0.23
Book Value (p.s.) 9.22
Profit Margin (%) -7.4
Operating Margin (%) -28.7
Return on Assets (ttm) -5.3
Return on Equity (ttm) -3.8
Qtrly Rev. Growth 1.3
Gross Profit (p.s.) 1.56
Sales Per Share 3.94
EBITDA (p.s.) -0.69
Qtrly Earnings Growth 0
Operating Cash Flow -58 (M)
Levered Free Cash Flow -66 (M)

Stock Valuations

PE Ratio 24.22
PEG Ratio -7.7
Price to Book value 1.04
Price to Sales 2.45
Price to Cash Flow -20.59

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.